ADAP Advocacy Report Highlights Medical Debt Crisis Despite $66 Billion 340B Drug Pricing Program
ADAP Advocacy's new infographics reveal that while the 340B Drug Pricing Program has grown to $66 billion primarily benefiting hospitals, patients continue facing aggressive medical debt collection and financial hardship.
ADAP Advocacy has published two new infographics examining the relationship between the 340B Drug Pricing Program and the growing medical debt crisis affecting American patients. The infographics, part of the organization's 340B Project, reveal that despite the program's $66 billion size and intended purpose of helping low-income patients access healthcare, medical debt remains a devastating financial burden for many Americans.
The first infographic, titled '340B Too Big to Fail – Medical Debt – Part 1,' demonstrates how the 340B program was originally designed to assist impoverished patients in obtaining healthcare services. However, the analysis shows that while the program has expanded significantly, primarily benefiting hospitals, patients continue to struggle with overwhelming medical debt, with most of this debt owed to the very hospitals that participate in the 340B program.
The second infographic, '340B Too Big to Fail – Medical Debt – Part 2,' documents how many 340B-participating hospitals employ aggressive, predatory debt collection practices that often damage patients' credit reports. According to the findings, these hospitals frequently choose not to set reasonable prices or offer robust financial assistance programs, instead opting to sue patients rather than provide the free charity care required by law.
The infographic series is available for download at https://www.adapadvocacy.org/publications.html#i and forms part of ADAP Advocacy's ongoing national campaign questioning whether the 340B Drug Pricing Program has become 'too big to fail.' The findings raise serious concerns about the program's effectiveness in achieving its original mission of helping vulnerable patients access affordable healthcare.
The report's implications are significant for healthcare policy, suggesting that despite massive financial resources flowing through the 340B program, systemic issues persist in protecting patients from medical debt and ensuring that program benefits actually reach those most in need. The documentation of aggressive collection practices by 340B hospitals highlights potential regulatory gaps in program oversight and enforcement.